| 英文别名 |
2-Propenamide, N-[5-[[4-(1-cyclopropyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxyphenyl]-, compd. with methanesulfonate (1:1);Almonertinib mesylate;2-Propenamide, N-[5-[[4-(1-cyclopropyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxyphenyl]-, methanesulfonate (1:1);MS-30791;Aumolertinib mesilate;EQ-143 MESYLATE;N-(5-((4-(1-Cyclopropyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl)acrylamide methanesulfonate;RZ6I9WX68U;UNII-RZ6I9WX68U;HS-10296 (mesylate);Almonertinib (mesylate);EQ143 MESYLATE;N-(5-((4-(1-cyclopropyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl)acrylamide mesylate;HS-10296 Methanesulfonate;N-(5-((4-(1-cyclopropyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl)acrylamide methanesulfonate (1:1);Aumolertinib mesylate;AKOS040759998;EX-A6602;HS-10296 Mesylate;D12259;Aumolertinib mesylate [USAN];2134096-06-1;Aumolertinib mesylate (USAN);HY-112823A;DA-70717;EQ 143 MESYLATE;CS-0066156;CHEMBL5095491;Aumolertinib mesilate [WHO-DD] |
微信公众号
客服
